Solid Pseudopapillary Carcinoma Of Pancreas
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
—
Drugs
(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate,
26 base single stranded phosphodiester DNA oligonucleotide,
3-bromopyruvate
(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate,
26 base single stranded phosphodiester DNA oligonucleotide,
3-bromopyruvate,
4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one,
4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one,
5'-O-(trans-9''-octadecenoyl)-1-beta-D-2'deoxy-2',2'-difluorocytidine,
5,10-methylene-tetrahydrofolic acid,
5-10-Methylene-tetrahydrofolate,
Adenoviral vector of serotype 5 modified to contain a chimeric sequence consisting of a minimal urokinase-type plasminogen activator receptor promoter preceded by three Notch-responsive elements, and coated with oligopeptide end-modified poly (beta-amino) esters,
Algenpantucel-L,
Antroquinonol,
Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand,
Axitinib
(
INLYTA
),
Bevacizumab
(
Equidacent,
AVASTIN,
Aybintio,
MVASI
),
Bovine bile extract,
Brivudine,
Chimeric antibody to mesothelin,
Chimeric monoclonal antibody against claudin-18 splice variant 2,
Cisplatin (liposomal),
Cysteamine bitartrate
(
CYSTAGON
),
Cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate,
Demcizumab,
Deuterium oxide,
Devimistat,
Eryaspase
(
GRASPA
),
G17(9) gastrin-diphtheria toxoid conjugate,
GVAX,
Genetically modified human adenovirus encoding human PH20 hyaluronidase,
Glufosfamide,
Heat killed whole cell mycobacterium obuense,
Heparan sulfate mimetic,
Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter,
Human telomerase reverse transcriptase peptide (611-626),
Human trtravalent, bi-specific monoclonal antibody that binds and co-inhibits two growth factor receptors; insulin-like growth factor receptor 1 (IGF-1R) and v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (ErbB3),
Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2,
Humanized IgG monoclonal antibody hRS7 conjugated to topoisomerase I inhibitor,
Immunoglobulin G1, anti-(human tumour-associated calcium signal transducer 2)(human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 ê-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl][...][3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,
Iodine (131I) anti-CEA sheep-human chimeric monoclonal antibody,
Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin,
Masitinib mesilate,
Mixture of seven synthetic fragments consisting of p21 RAS peptides,
Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL,
N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride,
N1,N14,-diethyl-3,12,-dihydroxyhomospermine,
Nanoliposomal irinotecan
(
ONIVYDE
),
Nimotuzumab
(
THERALOC
),
PEGylated recombinant human hyaluronidase PH20,
Paclitaxel (liposomal),
Paclitaxel protein-bound particles
(
ABRAXANE
),
Pegylated recombinant human interleukin-10,
Polyinosine-polycytidylic acid coupled with the polycationic polyethyleneimine,
Re188 P2045 somatostatin analog,
Recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen,
Relacorilant,
Rubitecan,
S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinyl-GNNDESNISFKEK,
Salirasib,
Targeted Gastrin 17 Complexed Peptide,
Trabedersen,
Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1,
[5-amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone,
human reovirus type 3 Dearing strain,
motixafortide,
sodium 2-hydroxylinoleate
Registered!
Solid pseudopapillary carcinoma of the pancreas is a rare carcinoma of the pancreas characterized by a variable combination of nonspecific signs and symptoms, such as abdominal pain, jaundice, abdominal fullness, anorexia, nausea, vomiting, and weight loss. One-third of the patients are asymptomatic. The tumor has low malignant potential, but can invade locally.